Loading clinical trials...
Loading clinical trials...
To investigate the effects of intravitreal and intracameral injection of dexamethasone during cataract phacoemulsification in patients with mild to moderate non-proliferative diabetic retinopathy
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Affiliated Hospital of Nantong University
NCT07354477 · Non-proliferative Diabetic Retinopathy (NPDR), Open-angle Glaucoma (OAG), and more
NCT05393284 · Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy
NCT07236645 · Non-proliferative Diabetic Retinopathy (NPDR)
NCT07230184 · Non-Proliferative Diabetic Retinopathy
NCT06487845 · Chronic Kidney Disease, Non-proliferative Diabetic Retinopathy, and more
Eye Institute, Affiliated Hospital of Nantong University
Nantong, Jiangsu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions